Immunomodulatory effects of drugs of abuse and the importance of structure-immunomodulatory activity studies.
Rapaka
R S
RS
Medications Development Division, National Institute on Drug Abuse, Rockville, MD 20857.
Hoiberg
C P
CP
D000818:Animals; D003042:Cocaine / Q000633:toxicity; D013759:Dronabinol / Q000633:toxicity; D004723:Endorphins / Q000494:pharmacology; D006801:Humans; D013287:Illicit Drugs / Q000633:toxicity*; D007107:Immune System / Q000187:drug effects*; D009294:Narcotics / Q000494:pharmacology; D013329:Structure-Activity Relationship
D004723:Endorphins; D013287:Illicit Drugs; D009294:Narcotics; D013759:Dronabinol; D003042:Cocaine